Disable Preloader


Florian Rieder, Joe Arron, Orit Rozenblatt- Rosen

This unique cross-organ, cross-disease discussion forum will host the transferrable insights you need from IPFNASH, scleroderma, IBD and more, in one place at one time, so you can more confidently demonstrate the antifibrotic effect in the clinic and address pathological fibrosis across multiple diseases. 

Hear from 35+ industry heavyweights including Genentech, AstraZenecaFDA, GSK, Boehringer IngelheimPfizerTakeda, and more to understand transformative mechanistic strategies for promoting tissue regeneration and repair, discover more robust predictive models to improve translatability; and assess emerging non-invasive biomarkers that identify early signs of efficacy and drive successful clinical trials